MANIPALHOS

Manipal Health Enterprises Limited · NSE · INE459N01021 · 41 sessions on record

₹696.00▼ −12.30 · −1.7%from ₹708.30 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹701.60
High: ₹710.10
Low: ₹683.00
Day's range: ₹273.8% of the previous close
VWAP: ₹695.85close +0.02% from it
Volume, shares: 9.8 L0.68× the 20-session average
Turnover, ₹ crore: 68
Trades: 46,00021 shares per trade
Previous close: ₹708.30−12.30 to the close
Price band, next session: ₹626.40 – ₹765.6010% either side of the close · dynamic, widened in 5% steps when hit

Day range48% of the way up

₹683.00₹710.10

52-week range37% of the way up

₹625.45 6 Aug₹815.00 28 Aug

−15% from the high · +11% from the low

Futures and options

No derivatives listed on MANIPALHOS

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up41 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

41 sessions on file · from 5 Aug

MANIPALHOS close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹696.00▼ −1.7% on the previous close
Against Nifty 50: Nifty −0.9%−0.9 pp difference on the day
Against the averages: below 2020-session ₹727.68 (−4.4%)
Volume: 0.68×the previous 20 sessions · 9.8 L shares
Extremes on the day: none

Quarterly results

consolidated · latest filed 30 Jun, 05:30 am IST · NSE filings

Revenue ₹3,091 cr; profit ₹243 cr in the Jun 2026 quarter, consolidated.

Last 1 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of MANIPALHOS on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 30 Jun	₹3,091 cr	—	₹243 cr	—	1.96	—not reached

Fundamentals

consolidated · filings to Jun 2026 · close ₹696.00 on 1 Oct

market cap ₹92,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹92,000 cron 1 Oct · free float ₹26,000 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: —no balance sheet filed yet
Book value a share: —no equity line in the filing
Debt to equity: —no equity line in the filing
Return on equity: —needs two filed balance sheets
Dividend yield: —no dividend with an ex-date in 365 days
Face value: ₹2a share
Shares outstanding: 132 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Hospital · F&O stocks with filings on record · industry P/E 58, market caps over trailing profit of 4 stocks

Stocks in the BSE sub-group Hospital with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
APOLLOHOSPApollo Hospitals Enterprise Limited	1,20,000 cron 1 Oct	56consolidated	12	₹8,133.50
MAXHEALTHMax Healthcare Institute Limited	92,000 cron 1 Oct	63consolidated	8.5	₹940.95
MANIPALHOSManipal Health Enterprises Limited	92,000 cron 1 Oct	—	—	₹696.00
ASTERDMAster DM Quality Care Limited	62,000 cron 1 Oct	—	13	₹708.90
FORTISFortis Healthcare Limited	59,000 cron 1 Oct	57consolidated	5.8	₹785.00
MEDANTAGlobal Health Limited	36,000 cron 1 Oct	—	9.2	₹1,357.30
NHNarayana Hrudayalaya Ltd.	36,000 cron 1 Oct	—	7.8	₹1,741.40
KIMSKrishna Institute of Medical Sciences Limited	31,000 cron 1 Oct	—	12	₹736.25
AGARWALEYEDr. Agarwal's Health Care Limited	15,000 cron 1 Oct	—	7.3	₹486.45
RAINBOWRainbow Childrens Medicare Limited	13,000 cron 1 Oct	—	7.8	₹1,279.80
PARKHOSPSPark Medi World Limited	12,000 cron 1 Oct	—	5.6	₹270.80
HCGHealthcare Global Enterprises Limited	10,000 cron 1 Oct	—	7.1	₹668.75
YATHARTHYatharth Hospital & Trauma Care Services Limited	10,000 cron 1 Oct	—	5.5	₹1,033.70
JLHLJupiter Life Line Hospitals Limited	8,500 cron 1 Oct	—	5.5	₹259.85
KOVAIKovai Medical Center & Hospital Limited	6,600 cron 1 Oct	—	—	₹5,993.50
ARTEMISMEDArtemis Medicare Services Limited	5,300 cron 1 Oct	—	5.7	₹336.40
INDRAMEDCOIndraprastha Medical Corporation Limited	3,100 cron 1 Oct	—	4.2	₹338.60
KMCSHILK M C Speciality Hospitals (India) Limited	2,800 cron 1 Oct	—	—	₹171.95
DRAGARWQDr Agarwals Eye Hospital Limited	2,500 cron 1 Oct	—	—	₹5,159.00
GKSLGujarat Kidney And Super Speciality Limited	1,500 cron 1 Oct	77consolidated	6.0	₹194.25
SHALBYShalby Limited	1,400 cron 1 Oct	—	1.4	₹133.55
GPTHEALTHGPT Healthcare Limited	1,200 cron 1 Oct	—	4.6	₹151.45
MOMSBELIEFRays of Belief Limited	470 cron 1 Oct	—	—	₹226.90
LOTUSEYELotus Eye Hospital and Institute Limited	240 cron 1 Oct	—	4.0	₹115.70

Shareholding

quarter to 4 Aug · none pledged · NSE filings

Promoters hold 72.1%, foreign portfolio investors 3.7%, mutual funds 3.5% and insurance companies 0.6%, as filed for the quarter to 4 Aug.

72.1%16.5%

By category, last 1 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of MANIPALHOS by category over the last 1 quarters with the change against the previous quarter
Category	4 Aug
Promoters	72.08
Foreign portfolio investors	3.66
Mutual funds	3.53
Insurance companies	0.63
Banks and financial institutions	1.30
Individual investors	2.35
Bodies corporate	0.27
Other foreign holders	15.96
Others	0.23

Corporate actions

NSE and BSE records

No corporate action on record for MANIPALHOS yet.

Price history

41 sessions on record · to 1 Oct · NSE end of day

MANIPALHOS is −2.0% over 20 sessions against Nifty's −6.2%, 15% below its 52-week high, realised volatility 34% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	MANIPALHOS %	Nifty 50 %	Difference pp
20 sessionssince 2 Sept	₹709.91	▼ −2.0%	▼ −6.2%	+4.3
5 sessionssince 24 Sept	₹742.48	▼ −6.3%	▼ −2.8%	−3.5
1 sessionsince 30 Sept	₹708.32	▼ −1.7%	▼ −0.88%	−0.86

Averages of the closeclose against each average

5-session average: ₹720.41close −3.4% from it
20-session average: ₹727.68close −4.4% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹273.9% of the close
Average day's range, 20: ₹243.4% of the close
Volume against 20 sessions: 0.68×9.8 L vs 13 L average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 34%≈ ±2.2% a session · moved more than that on 7 of 20

Up and down sessionscloses above and below the previous close

Last 20 sessions: 10 up · 10 downof 20
Best session, 250: ▲ +4.2%26 Aug
Worst session, 250: ▼ −5.3%30 Sept

Manipal Health Enterprises Limited is in 1 NSE index

Nifty IPO

0 bulletins on MANIPALHOS

The desk has not written about Manipal Health Enterprises Limited yet. The tape carries every bulletin as it is published.

About Manipal Health Enterprises Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Manipal Health Enterprises Limited
Exchange: NSE · BSE 544847, group B
Listed on NSE: 5 Aug 2026
Classification: Healthcare › Healthcare Services › Hospital
Index: BSE IPO
Face value: ₹2 a share
ISIN: INE459N01021
Sessions on record: 41
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 1 Oct, 08:02 pm IST
Bulletins: 0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.